Featured Research

from universities, journals, and other organizations

Iowa Researchers Identify Possible Reason For Rare, Accelerated Aging Condition

Date:
May 24, 1999
Source:
University Of Iowa
Summary:
A University of Iowa study looking at a rare, accelerated aging condition could improve understanding of normal aging and lead to treatments for various problems, including the accelerated aging condition itself, heart disease, stroke, cancer, and Alzheimer's and Parkinson's diseases.

IOWA CITY, Iowa -- A University of Iowa study looking at a rare, accelerated aging condition could improve understanding of normal aging and lead to treatments for various problems, including the accelerated aging condition itself, heart disease, stroke, cancer, and Alzheimer's and Parkinson's diseases.

UI researchers have found that people with progeria have extremely low levels of antioxidant enzymes. Progeria is a disease that mimics normal aging but occurs at a very fast pace. The antioxidant enzymes, deficient in individuals with progeria, protect most people against cell-damaging free radicals known as reactive oxygen species (ROS).

"Understanding the molecular mechanism underlying progeria may help to further explain the molecular basis of normal aging, " said Larry Oberley, Ph.D., UI professor of radiology and the study's lead investigator.

Progeria cells are ideal for the study of aging because they mimic the aging process without the time it would take in normal models. Investigating the process would require three years in mice and 40 years in monkeys, Oberley said. The progeria research, by contrast, took three months.

In their investigation, the UI researchers found that progeria cells demonstrate only 50 percent of normal catalase activity and 30 percent of normal glutathione peroxidase activity. Catalase and glutathione peroxidase are two of the four primary antioxidant enzymes. The lack of these two enzymes makes it impossible for the cells to effectively remove toxic peroxides produced during normal cell metabolism.

Reintroducing antioxidant enzymes into the cells may halt or reverse the problem. To accomplish this, the UI investigators plan to use adenovirus gene transfers. This approach involves attaching the enzymes to a disabled common cold virus and then giving it to patients. The virus, acting as a transporter, takes the enzymes to the necessary cells.

Manipulating antioxidant enzymes might be beneficial for treating a number of diseases. As Oberley explained, "Everything in a cell is about balance." In some cases, such as progeria, adding antioxidant enzymes restores the balance, allowing the cell to live. In other cases, such as cancer, adding the enzymes disrupts the balance, causing the cells to die.

"You use the same reagents, just in different ways," Oberley said. "We're just on the edge of radical medical advancement. We're talking about possible treatments for cancer, aging, heart attacks -- most of the diseases of mankind."

UI researchers plan to use their gene transfer strategy to try to treat some of these other conditions.

The UI progeria findings are included in a recent issue of Biochemical and Biophysical Research Communications. The National Institutes of Health provided funding for the research.


Story Source:

The above story is based on materials provided by University Of Iowa. Note: Materials may be edited for content and length.


Cite This Page:

University Of Iowa. "Iowa Researchers Identify Possible Reason For Rare, Accelerated Aging Condition." ScienceDaily. ScienceDaily, 24 May 1999. <www.sciencedaily.com/releases/1999/05/990524040058.htm>.
University Of Iowa. (1999, May 24). Iowa Researchers Identify Possible Reason For Rare, Accelerated Aging Condition. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/1999/05/990524040058.htm
University Of Iowa. "Iowa Researchers Identify Possible Reason For Rare, Accelerated Aging Condition." ScienceDaily. www.sciencedaily.com/releases/1999/05/990524040058.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins